Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3269401000168110 | Cyproterone Acetate (Apo) (cyproterone acetate 50 mg) tablet, 20 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3269411000168113 | Cyproterone Acetate (Apo) 50 mg tablet, 20, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cyproterone Acetate (Apo) 50 mg tablet, 20, bottle | Is a | Cyproterone Acetate (Apo) 50 mg tablet, 20 | true | Inferred relationship | Some | ||
| Cyproterone Acetate (Apo) 50 mg tablet, 20, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Cyproterone Acetate (Apo) 50 mg tablet, 20, bottle | has TPUU | Cyproterone Acetate (Apo) 50 mg tablet | true | Inferred relationship | Some | 1 | |
| Cyproterone Acetate (Apo) 50 mg tablet, 20, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Cyproterone Acetate (Apo) 50 mg tablet, 20, bottle | has TP | Cyproterone Acetate (Apo) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR